DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,256,090 | +1.9% | 25,216 | -1.4% | 0.27% | +5.4% |
| Q2 2023 | $6,142,428 | -9.7% | 25,569 | -5.2% | 0.26% | -7.9% |
| Q1 2023 | $6,800,681 | -7.2% | 26,958 | -2.3% | 0.28% | -11.9% |
| Q4 2022 | $7,327,738 | +0.5% | 27,586 | -2.2% | 0.32% | -4.5% |
| Q3 2022 | $7,288,000 | -11.0% | 28,195 | -12.6% | 0.33% | -15.1% |
| Q2 2022 | $8,188,000 | -14.4% | 32,269 | -1.0% | 0.39% | +0.3% |
| Q1 2022 | $9,567,000 | -2.7% | 32,593 | +9.2% | 0.39% | -7.3% |
| Q4 2021 | $9,829,000 | +10.5% | 29,859 | +2.2% | 0.42% | +0.7% |
| Q3 2021 | $8,896,000 | +3.4% | 29,203 | -8.9% | 0.42% | +3.7% |
| Q2 2021 | $8,605,000 | +18.2% | 32,045 | -2.2% | 0.40% | +8.6% |
| Q1 2021 | $7,283,000 | -0.0% | 32,765 | 0.0% | 0.37% | -19.0% |
| Q4 2020 | $7,284,000 | -5.2% | 32,765 | -8.1% | 0.46% | -18.2% |
| Q3 2020 | $7,685,000 | +17.9% | 35,664 | -3.2% | 0.56% | +23.3% |
| Q2 2020 | $6,521,000 | +20.7% | 36,845 | -5.5% | 0.46% | -0.9% |
| Q1 2020 | $5,404,000 | +10.7% | 38,999 | +22.8% | 0.46% | +42.1% |
| Q4 2019 | $4,881,000 | +11.5% | 31,769 | +4.9% | 0.32% | +4.9% |
| Q3 2019 | $4,377,000 | +0.7% | 30,274 | -0.4% | 0.31% | -2.2% |
| Q2 2019 | $4,347,000 | -11.9% | 30,384 | -18.6% | 0.32% | -12.0% |
| Q1 2019 | $4,936,000 | +42.2% | 37,338 | +11.1% | 0.36% | +17.4% |
| Q4 2018 | $3,472,000 | -2.9% | 33,621 | +2.4% | 0.30% | +3.4% |
| Q3 2018 | $3,574,000 | -13.7% | 32,845 | -21.6% | 0.30% | -12.5% |
| Q2 2018 | $4,141,000 | -7.8% | 41,895 | -8.5% | 0.34% | -0.3% |
| Q1 2018 | $4,492,000 | +2.4% | 45,802 | -2.9% | 0.34% | +11.6% |
| Q4 2017 | $4,385,000 | +1.4% | 47,172 | -6.3% | 0.30% | +0.3% |
| Q3 2017 | $4,326,000 | -20.2% | 50,365 | -21.5% | 0.30% | -25.4% |
| Q2 2017 | $5,424,000 | -5.4% | 64,187 | -4.1% | 0.40% | -8.4% |
| Q1 2017 | $5,733,000 | +5.3% | 66,937 | -4.2% | 0.44% | +1.6% |
| Q4 2016 | $5,447,000 | -23.4% | 69,891 | -0.6% | 0.44% | -26.4% |
| Q3 2016 | $7,114,000 | 0.0% | 70,342 | 0.0% | 0.59% | -0.2% |
| Q2 2016 | $7,114,000 | +8.3% | 70,342 | +1.8% | 0.59% | +3.1% |
| Q1 2016 | $6,566,000 | +2.4% | 69,110 | +0.3% | 0.57% | -5.0% |
| Q4 2015 | $6,409,000 | +13.7% | 68,902 | +4.3% | 0.60% | +12.5% |
| Q3 2015 | $5,637,000 | -2.8% | 66,058 | -2.4% | 0.54% | +8.7% |
| Q2 2015 | $5,798,000 | +0.5% | 67,649 | -0.3% | 0.49% | +1.2% |
| Q1 2015 | $5,767,000 | -3.7% | 67,829 | -2.8% | 0.49% | +2.7% |
| Q4 2014 | $5,986,000 | +24.0% | 69,769 | +10.0% | 0.48% | +11.8% |
| Q3 2014 | $4,827,000 | +0.7% | 63,449 | +4.3% | 0.42% | +4.7% |
| Q2 2014 | $4,792,000 | +23.4% | 60,809 | +17.6% | 0.41% | +16.3% |
| Q1 2014 | $3,882,000 | +0.5% | 51,709 | +3.4% | 0.35% | +1.5% |
| Q4 2013 | $3,862,000 | +5.8% | 50,009 | -5.0% | 0.34% | +2.4% |
| Q3 2013 | $3,651,000 | +16.9% | 52,645 | +5.6% | 0.34% | +10.2% |
| Q2 2013 | $3,124,000 | – | 49,835 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |